Gemina Laboratories' market value is the price at which a share of Gemina Laboratories trades on a public exchange. It measures the collective expectations of Gemina Laboratories investors about its performance. Gemina Laboratories is trading at 0.43 as of the 31st of January 2025. This is a 7.50 percent increase since the beginning of the trading day. The stock's lowest day price was 0.43. With this module, you can estimate the performance of a buy and hold strategy of Gemina Laboratories and determine expected loss or profit from investing in Gemina Laboratories over a given investment horizon. Check out Gemina Laboratories Correlation, Gemina Laboratories Volatility and Gemina Laboratories Alpha and Beta module to complement your research on Gemina Laboratories.
Please note, there is a significant difference between Gemina Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gemina Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gemina Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gemina Laboratories 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gemina Laboratories' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gemina Laboratories.
0.00
02/11/2023
No Change 0.00
0.0
In 1 year 11 months and 22 days
01/31/2025
0.00
If you would invest 0.00 in Gemina Laboratories on February 11, 2023 and sell it all today you would earn a total of 0.00 from holding Gemina Laboratories or generate 0.0% return on investment in Gemina Laboratories over 720 days. Gemina Laboratories is related to or competes with Novo Nordisk, Genmab A/S, Inhibikase Therapeutics, Purple Biotech, Synaptogenix, Sino Biopharmaceutica, and GT Biopharma. Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vit... More
Gemina Laboratories Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gemina Laboratories' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gemina Laboratories upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gemina Laboratories' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gemina Laboratories' standard deviation. In reality, there are many statistical measures that can use Gemina Laboratories historical prices to predict the future Gemina Laboratories' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Gemina Laboratories. Your research has to be compared to or analyzed against Gemina Laboratories' peers to derive any actionable benefits. When done correctly, Gemina Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Gemina Laboratories.
Gemina Laboratories Backtested Returns
Gemina Laboratories appears to be out of control, given 3 months investment horizon. Gemina Laboratories holds Efficiency (Sharpe) Ratio of 0.0865, which attests that the entity had a 0.0865 % return per unit of risk over the last 3 months. By evaluating Gemina Laboratories' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please utilize Gemina Laboratories' Downside Deviation of 11.68, market risk adjusted performance of 0.4272, and Risk Adjusted Performance of 0.0812 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Gemina Laboratories holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of 1.67, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gemina Laboratories will likely underperform. Please check Gemina Laboratories' maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to make a quick decision on whether Gemina Laboratories' current trending patterns will revert.
Auto-correlation
-0.03
Very weak reverse predictability
Gemina Laboratories has very weak reverse predictability. Overlapping area represents the amount of predictability between Gemina Laboratories time series from 11th of February 2023 to 6th of February 2024 and 6th of February 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gemina Laboratories price movement. The serial correlation of -0.03 indicates that only 3.0% of current Gemina Laboratories price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.03
Spearman Rank Test
-0.06
Residual Average
0.0
Price Variance
0.01
Gemina Laboratories lagged returns against current returns
Autocorrelation, which is Gemina Laboratories otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gemina Laboratories' otc stock expected returns. We can calculate the autocorrelation of Gemina Laboratories returns to help us make a trade decision. For example, suppose you find that Gemina Laboratories has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Gemina Laboratories regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gemina Laboratories otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gemina Laboratories otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gemina Laboratories otc stock over time.
Current vs Lagged Prices
Timeline
Gemina Laboratories Lagged Returns
When evaluating Gemina Laboratories' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gemina Laboratories otc stock have on its future price. Gemina Laboratories autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gemina Laboratories autocorrelation shows the relationship between Gemina Laboratories otc stock current value and its past values and can show if there is a momentum factor associated with investing in Gemina Laboratories.
Other Information on Investing in Gemina OTC Stock
Gemina Laboratories financial ratios help investors to determine whether Gemina OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.